Clinical Epidemiology Unit, Karolinska Institutet, Department of Medicine Solna, Stockholm, Sweden
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
RMD Open. 2024 Aug 20;10(3):e004532. doi: 10.1136/rmdopen-2024-004532.
The objectives of this study are to study the risk of developing cardiac arrhythmia and its subtypes over time in patients with systemic sclerosis (SSc), to assess potential risk factors for arrhythmia in SSc and to explore whether arrhythmia is associated with mortality.
We used nationwide Swedish registers to identify patients with incident SSc 2004-2019 and matched general population comparators (1:10). The primary outcome was incident arrhythmia. Follow-up started at the date of SSc diagnosis and ended at the primary outcome, death, emigration or 31 December 2019. We estimated the incidence of arrhythmia overall and stratified by subtype and explored the relative risk in relation to time since diagnosis using flexible parametric models. We used Cox regression to study risk factors for arrhythmia and the association of arrhythmia with mortality.
We identified 1565 patients and 16 009 comparators. The overall incidence of arrhythmia was 255 (95% CI 221 to 295) and 119 (95% CI 112 to 127) per 10 000 person years in patients with SSc and comparators, respectively, corresponding to an IRR of 2.1 (95% CI 1.8 to 2.5). The greatest hazard difference between patients with SSc compared with the comparators was seen in the first year of follow-up (HR for arrhythmia 3.0; 95% CI 2.3 to 3.8). Atrial fibrillation and flutter were the most common arrhythmia subtypes. Male sex, index age and pulmonary arterial hypertension were significant risk factors for arrhythmia in SSc. Incident arrhythmia was significantly associated with mortality (HR 2.2; 95% CI 1.6 to 3.0).
SSc is associated with higher incidence of cardiac arrhythmia compared with general population. Arrhythmia seems to be an early manifestation of SSc and is associated with higher mortality.
本研究旨在研究系统性硬化症(SSc)患者随时间发生心律失常及其亚型的风险,评估 SSc 中心律失常的潜在危险因素,并探讨心律失常是否与死亡率相关。
我们使用全国性的瑞典登记处,确定了 2004 年至 2019 年期间发生的 SSc 患者,并与一般人群进行了 1:10 的匹配。主要结局是心律失常的发生。随访从 SSc 诊断日期开始,直至主要结局、死亡、移民或 2019 年 12 月 31 日结束。我们估计了心律失常的总体发生率,并按亚型进行分层,使用灵活的参数模型探讨了与诊断后时间的相对风险。我们使用 Cox 回归分析了心律失常的危险因素以及心律失常与死亡率的关系。
我们确定了 1565 名患者和 16009 名对照者。SSc 患者的心律失常总发生率为 255(95%CI 221 至 295)和 119(95%CI 112 至 127)每 10000 人年,相应的发病率比为 2.1(95%CI 1.8 至 2.5)。与对照组相比,SSc 患者的最大危险差异出现在随访的第一年(心律失常的 HR 为 3.0;95%CI 2.3 至 3.8)。心房颤动和心房扑动是最常见的心律失常类型。男性、指数年龄和肺动脉高压是 SSc 中心律失常的显著危险因素。新发心律失常与死亡率显著相关(HR 2.2;95%CI 1.6 至 3.0)。
与一般人群相比,SSc 患者心律失常的发生率更高。心律失常似乎是 SSc 的早期表现,与更高的死亡率相关。